Your browser doesn't support javascript.
loading
TuBG1 promotes hepatocellular carcinoma via ATR/P53-apoptosis and cycling pathways.
Zhang, Yan; Wang, Zhen-Zhen; Han, An-Qi; Yang, Ming-Ya; Zhu, Li-Xin; Pan, Fa-Ming; Wang, Yong.
Afiliação
  • Zhang Y; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei 230601, China.
  • Wang ZZ; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Han AQ; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Yang MY; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Zhu LX; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, China.
  • Pan FM; Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei 230032, China; The Key Laboratory of Major Autoimmune Diseases, Anhui Medical University, Hefei 230032, China.
  • Wang Y; Department of General Surgery, The Second Hospital of Anhui Medical University, Hefei 230601, China. Electronic address: wangyong@ahmu.edu.cn.
Hepatobiliary Pancreat Dis Int ; 23(2): 195-209, 2024 Apr.
Article em En | MEDLINE | ID: mdl-37806848

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article